Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.22.1
Consolidated Statements of Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Comprehensive Income [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 2 $ 11,757,037 $ (11,115,178) $ (2,152) $ 639,709
Beginning balance, shares at Dec. 31, 2019 25,690        
Issuance of common stock from convertible debt $ 70 687,664 687,734
Issuance of common stock from convertible debt, shares 699,800        
Beneficial conversion feature of convertible debt 1,136,901 1,136,901
Issuance of common stock for options exercised $ 9 (9)
Issuance of common stock for options exercised, shares 85,960       106,200
Stock-based compensation in connection with options granted 830,900 $ 830,900
Stock-based compensation in connection with restricted stock awards $ 1 73,999 74,000
Stock-based compensation in connection with restricted stock awards, shares 6,000        
Issuance of common stock from exercise of warrant      
Issuance of common stock from exercise of warrant, shares      
Issuance of common stock related to June offering        
Issuance of common stock related to offering, shares      
Issuance of common for over-allotment      
Issuance of common for over-allotment, shares      
Issuance of warrants for over-allotment      
Comprehensive gain (40,680) (40,680)
Net loss (2,763,375) (2,763,375)
Ending balance, value at Dec. 31, 2020 $ 82 14,486,492 (13,878,553) (42,832) 565,189
Ending balance, shares at Dec. 31, 2020 817,450        
Issuance of common stock from convertible debt $ 135 1,644,132 1,644,267
Issuance of common stock from convertible debt, shares 1,345,468        
Beneficial conversion feature of convertible debt 340,420 340,420
Issuance of common stock for options exercised $ 2 4,998 $ 5,000
Issuance of common stock for options exercised, shares 17,437       19,200
Stock-based compensation in connection with options granted 1,277,353 $ 1,277,353
Stock-based compensation in connection with restricted stock awards $ 63 2,481,008 2,481,071
Stock-based compensation in connection with restricted stock awards, shares 634,883        
Issuance of common stock from exercise of warrant $ 92 4,629,448 4,629,540
Issuance of common stock from exercise of warrant, shares 925,908        
Issuance of common stock related to June offering $ 288 12,661,696 12,661,984
Issuance of common stock related to offering, shares 2,880,000        
Issuance of common for over-allotment $ 43 1,983,226 1,983,269
Issuance of common for over-allotment, shares 432,000        
Issuance of warrants for over-allotment 4,320 4,320
Comprehensive gain 46,068 46,068
Net loss (8,107,662) (8,107,662)
Ending balance, value at Dec. 31, 2021 $ 705 $ 39,513,093 $ (21,986,215) $ 3,236 $ 17,530,819
Ending balance, shares at Dec. 31, 2021 7,053,146